HALRIC – increasing life science research and innovation infrastructure synergies in Northern Europe

Medicon Village

Southern Scandinavia and Northern Germany form a leading life science region with unique research infrastructures that can help transform research into innovation. There is especially a large unused potential for industrial and clinical researchers to use these unique facilities. The HALRIC (Hanseatic Life Science Research Infrastructure Consortium) led by Lund University and Medicon Valley now starts to build collaborations between key stake holders within the region, to utilize these unique research techniques and competencies.

– The opportunities for research and innovation using large-scale facilities are for many user communities underexploited. Especially for medical research, linking expertise to less experienced users is important to further this community. The HALRIC project is an excellent opportunity to engage new users, create critical mass and strengthen the collaborations not only between universities but also with industry, says Erik Renström, vice-chancellor of Lund University.

The initiative aims at increasing engagement of companies and hospitals in research collaborations with both small and large-scale infrastructures (MAX IV, ESS, EuXFEL and DESY), through supporting collaborative pilot projects. The consortium will also work on prototype models for handling the huge amounts of electronic data generated by such highly-specialised infrastructures, and on strengthening the life science ecosystems and strategic dialogues between the participating countries' engaged partners:

  • SWEDEN: Lund University, Malmö University, MAX IV, ESS, Skåne University Hospital, Region Skåne, Medicon Village.
  • DENMARK: University of Copenhagen, Technical University of Denmark, Aarhus University, University of Southern Denmark, Rigshospitalet/Region Hovedstaden, Medicon Valley Alliance.
  • GERMANY: University of Hamburg, EMBL, DESY, European XFEL, University Hospital Hamburg-Eppendorf, City of Hamburg, Life Science Nord.
  • NORWAY: University of Oslo.

The project spans from April 2023 to July 2026, and is co-financed by EU Interreg Öresund-Kattegat-Skagerrak.


More information: